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CASE
In April 2017, a 56-year-old HIV-positive man was transferred from another institutionto our regional infectious disease unit having presented with 2 weeks of profuse,
watery diarrhea accompanied by intermittent, fresh bleeding of the rectum. Symptoms
had started during a 2-month vacation to Indonesia, Vietnam, and Malaysia. While on
vacation, he stayed in hotels in urban areas, had no rural travel, and drank only bottled
water. He reported that he was not a man who has sex with men (MSM) and preferred
to discuss his further sexual history conﬁdentially with the genitourinary medicine
team. Two months prior to admission, his CD4 count was 194 cells/mm3, and while
taking an antiretroviral therapy regimen consisting of tenofovir, emtricitabine, and
nevirapine, his HIV RNA had been undetectable in his plasma for 3 years.
Initial investigations showed a raised C-reactive protein (CRP) level (282 mg/liter;
normal, 5 mg/liter), neutrophilia (12.9  109/liter; normal, 2.0 to 7.5  109/liter), a
prolonged prothrombin time (19.8 s; normal, 9 to 13 s), and a mild transaminitis
(alanine aminotransferase, 55 U/liter; normal, 35 U/liter). Oral azithromycin was
started for presumed infective gastroenteritis, and intravenous (i.v.) ﬂuid resuscitation
was given. Routine fecal microscopy and cultures identiﬁed no bacteria, ova, cysts, or
parasites, and three routine blood cultures were negative.
Two days after transfer to our unit, the patient developed abdominal distension,
generalized peritonitis, and tachycardia, and his CRP level rose to 395 mg/liter. An
urgent contrast-enhanced computed tomography (CT) scan of his abdomen showed
severe pancolitis, with perforations of the cecum and sigmoid colon, and two small
low-density lesions in the liver. He was prescribed i.v. ceftriaxone and metronidazole
and underwent an emergency laparotomy. This revealed a gangrenous necrotic cecum
with gross disruption of its anterior wall and four-quadrant fecal contamination of the
peritoneal cavity. Serosal evidence of colitis was found throughout the colon but
diminished distally and spared the rectum. The colon was resected in a standard
manner, the distal sigmoid was transected, and the remaining rectal stump was sutured
to the anterior wall of the peritoneal cavity. A 10-liter peritoneal lavage was performed,
and a spouting end ileostomy was formed in the right iliac fossa.
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Lactobacillus rhamnosus and Streptococcus anginosus were isolated from intra-
abdominal drains, Enterococcus gallinarum and Escherichia coli were identiﬁed in sur-
gical wound swabs, and the patient continued on i.v. ceftriaxone and metronidazole.
Two weeks into his hospital stay, the patient developed cholestatic derangement of
liver function tests, with gamma-glutamyl transferase and alkaline phosphatase reach-
ing peaks of 2,946 U/liter (normal, 11 to 50 U/liter) and 2,046 U/liter (normal, 30 to 200
U/liter), respectively. A further liver CT scan showed no change in the lesions, which
radiologists reported as more likely to represent hemangiomas than amebic or pyo-
genic abscesses. Ceftriaxone was discontinued, which resulted in normalization of liver
function tests. Antimicrobial therapy was switched to tigecycline to complete treat-
ment of the patient’s resolving intra-abdominal sepsis while avoiding further derange-
ment of liver function tests.
The subtotal colectomy specimen was received by the histopathology department,
with a perforated necrotic cecum and associated ﬁbrinous exudate found on the serosa.
Upon opening the specimen, there were multiple, discrete, undermining ulcers with
hyperemic edges throughout the proximal and transverse colon, but the distal colon
and the terminal ileum were spared. The ulcers were of various sizes (1.5 to 2.0 cm),
were orientated transversely across the colon, and had necrotic yellow debris covering
the ulcer base (Fig. 1). The intervening mucosa was macroscopically normal. On
microscopy, there were foci of superﬁcial erosion of the colonic mucosa, undermining
ulceration into the submucosa (Fig. 2A), and transmural ulceration and necrosis,
including at the site of the perforation in the cecum (Fig. 2B). Within the ulcers, there
was abundant necrotic amorphous debris containing nuclear debris and the tropho-
zoites of amebae (30 m in size), some with ingested erythrocytes, but only scanty
neutrophils (Fig. 2C and D and inset). No amebic cysts were seen. The colon between
the ulcers was normal.
Amebic serology was strongly positive (titer, 1:512), and an ameba latex test of a
serum sample was positive. Amebiasis was treated for a total of 14 days with i.v.
metronidazole. This was followed by 7 days of oral paromomycin for luminal clearance.
Postoperatively, the patient had a prolonged ileus and required total parenteral
nutrition. Complications included a superﬁcial dehiscence of the abdominal wound and
a coagulopathy requiring correction. He was discharged after 5 weeks in the hospital
and completed 6 weeks of tigecycline therapy as an outpatient.
He was seen in our clinic in May 2018 and had gained 16 kg in weight. He was eating
a normal diet and able to use his stoma independently, and his surgical wound
dehiscence had healed well. The patient has been scheduled for an ileorectal anasto-
mosis procedure to restore bowel continuity. This will be followed by a further week of
FIG 1 Discrete ulcers (1.5 to 2.0 cm in size) with hyperemic edges and containing necrotic yellow debris
lie transversely within the colon. Arrows indicate the ulcers.
The Brief Case Journal of Clinical Microbiology
August 2018 Volume 56 Issue 8 e01703-17 jcm.asm.org 2
 o
n
 Septem
ber 12, 2018 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
oral paromomycin to eliminate any residual luminal Entamoeba histolytica organisms in
the remaining rectum.
DISCUSSION
Amebiasis is caused by Entamoeba histolytica, a protozoon commonly found in
low-resource settings, including Africa, India, Mexico, and parts of central/south Amer-
ica and Southeast Asia. The predominant risk factors for amebiasis include travel to or
residence in areas of endemicity, low socioeconomic status, being a man who has sex
with men (MSM), being institutionalized, extremes of age (young/old), pregnancy,
iatrogenic immunosuppression (including corticosteroids), alcoholism, malignancy, and
malnutrition (1). Amebic cysts are transmitted feco-orally (including during sexual
contact) (2), and the majority of infections are asymptomatic (1). However, in the small
intestine, cysts can develop into trophozoites. Trophozoites then penetrate the large
bowel mucosa, causing invasive disease, including dysentery, amebic liver abscesses
(ALA), and other extraintestinal manifestations.
Intestinal amebiasis presents 1 to 3 weeks following infection with symptoms,
including fever, abdominal pain, and bloody diarrhea. Fulminant amebic colitis with or
without toxic megacolon occurs rarely (1 in 200) but has a mortality of up to 40% (1).
FIG 2 (A) A discrete undermining (ﬂask-shaped) ulcer is separated by normal colon as observed with hematoxylin and eosin (H&E) staining. The long arrow
indicates the undermining ulcer, and short arrows indicate the normal colon. (B) Transmural ulceration and necrosis at the edge of the cecal perforation,
indicated by the long arrow (H&E staining). (C) Abundant amebae are seen in the amorphous eosinophilic necrotic material within the ulcers (H&E staining).
(D) Trophozoites have distinct cell membranes, abundant foamy cytoplasm, and an eccentric nucleus (inset, arrow) with peripheral chromatin margination and
a central karyosome (H&E staining).
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Extraintestinal manifestations of invasive amebiasis include ALA, brain abscesses, and
pleuropulmonary, cardiac, or cutaneous involvement. ALA are the most common
extraintestinal manifestation, occurring a median of 12 weeks following exposure
(although the lag period can be years). Symptoms of ALA include fever and upper right
quadrant pain, but jaundice is uncommon. Of note, less than one-third of patients with
ALA report concurrent diarrhea, but clinical history may reveal an episode of dysentery
in preceding months (1). Radiological imaging with CT or ultrasound may be charac-
teristic of ALA, with the majority of abscesses being solitary subcapsular lesions found
in the posterior part of the right lobe (3). However, imaging of the abdomen does not
differentiate colitis or perforation caused by invasive amebiasis from colitis or perfora-
tion of other etiology (3).
The evidence supporting a diagnosis of amebiasis in this patient was 2-fold, with
positive serology and pathology. The latex agglutination test is a rapid screening test
for circulating amebic antibody, which is performed on serum prior to the more
sensitive indirect ﬂuorescent assay (IFA). The IFA titer in a serum sample taken 10 days
into the illness was 1:512. Titers of greater than 1:256 are strongly suggestive of invasive
amebiasis, according to our local laboratory thresholds. The macroscopic and micro-
scopic appearances (described above) in the resection specimen were classical for
amebic colitis. Other serological assays are available to support the diagnosis of
amebiasis; enzyme-linked immunosorbent assay (ELISA) is the most commonly used
assay in clinical laboratories, predominantly because the IFA is more technically chal-
lenging to perform (4). Nevertheless, an IFA offers several advantages over an ELISA.
First, the IFA has higher sensitivity (93.6%) and speciﬁcity (96.7%). Second, IFA titers
drop 8 to 12 months posttherapy, whereas ELISA titers do not. This change in IFA titers,
coupled with serial measurement of IFA IgM levels, can be used to differentiate
between previous and current amebiasis and also to monitor response to treatment (4,
5). It should be noted that, despite our patient having severe invasive amebiasis with
a high burden of organisms in the colon, fecal microscopy was negative. Fecal micros-
copy is less reliable than the serological tests mentioned above because its sensitivity
is 33 to 50%. False-positive results can occur due to misidentiﬁcation of macrophages
as trophozoites or of polymorphonuclear cells as cysts or due to the presence of other
Entamoeba species (e.g., the morphologically identical but nonpathogenic Entamoeba
dispar). In settings in which diagnostic tests for amebiasis are limited to microscopy, the
detection rate can be increased to 85% by examining 3 fresh fecal samples over a
10-day period (1, 3, 4).
The aims of treatment of amebiasis are to eliminate invasive trophozoites and to
eradicate carriage of E. histolytica cysts in the intestine. The main treatment options
include metronidazole (500 to 750 mg three times a day orally for 10 days) or tinidazole
(2 g once daily for 3 days) for invasive disease. A systematic review suggested that
tinidazole had a reduced clinical failure rate and few side effects compared with
metronidazole (6). While metronidazole or tinidazole alone may eradicate intestinal cyst
carriage, a second luminal agent, such as paromomycin (25 to 30 mg per kg of body
weight per day for 7 days) or diloxanide furoate (500 mg three times a days for 10 days),
is still recommended (6).
There are a number of important points to note from this case. Our patient had been
in an area where amebae are endemic for a relatively short period of 2 months, staying
in good-quality accommodations. This is in line with evidence of an acknowledged risk
of amebiasis with even short periods of travel; one case series found that 35% of
travelers with ALA had spent less than 6 weeks in an area of endemicity (7). Being male
has also been recognized as a risk factor for ALA (7 to 10 times higher incidence) but
not amebic dysentery (8). Iatrogenic immunosuppression is a risk factor for severe
amebiasis (1), but an association with HIV-related immunosuppression is less clear; our
patient had well-controlled HIV disease on antiretroviral therapy without any WHO
grade 3 or 4 complications, but his CD4 count before this illness was only 194
cells/mm3, indicating the possibility of incomplete immune reconstitution.
Evidence of an association between amebiasis and HIV relates predominantly to
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ALA. A study in Japan showed that a high anti-E. histolytica antibody titer in newly
registered HIV patients was an independent predictor of developing invasive amebiasis
(9). Studies in Taiwan and Hong Kong suggest an increase in the prevalence of invasive
amebiasis in HIV-positive men, but this is potentially confounded by oro-anal sexual
contact (10, 11). One report from the United States found that, of patients with ALA
who had not visited areas of endemicity, 38% were HIV positive (12), and a further case
series found no difference in clinical and radiological presentation of patients with ALA
who were HIV positive or HIV negative (13). Overall, MSM may be at increased risk of
amebiasis, and clinicians should have a lower threshold of suspicion for the diagnosis
in relevant returning travelers, even those who have a short travel duration.
Luminal amebicidal treatment is recommended to eradicate colonic carriage and
prevent recurrence. However, we were faced with the conundrum of whether this was
necessary in this case, as the colon had been largely removed. On the presumption that
there was a high organism burden, given the severe disease, we gave paromomycin in
the immediate postoperative period. Oral preparations of paromomycin were expected
to reach only the small bowel and be cleared into the stoma; therefore, the rectal stump
remained untreated. As no rectal preparations are available, we decided to re-treat our
patient with paromomycin following the restoration of bowel continuity.
This rare case of invasive amebiasis requiring subtotal colectomy in an HIV-positive
man highlights a number of important learning points. First, invasive amebiasis should
be considered in returning travelers with diarrhea, even when duration of time spent
in an area of endemicity has been limited. Second, although MSMmay be at greater risk
of amebiasis, there is no convincing evidence to suggest that having HIV disease per se
increases the propensity to, or severity of, amebic disease. Finally, no rectal prepara-
tions of luminal agents are currently available, so once bowel continuity is restored in
this patient, we will commence a second course of luminal treatment to eliminate any
remaining amebae in the untreated rectum.
SELF-ASSESSMENT QUESTIONS
1. Which of the following is a proven risk factor for invasive amebiasis?
A. Being female
B. HIV infection
C. Inﬂammatory bowel disease
D. Prolonged antibiotic use
E. Travel to or residence in an area of endemicity
2. What is the most commonly used serological assay in the diagnosis of amebiasis?
A. Complement ﬁxation
B. ELISA (enzyme-linked immunosorbent assay)
C. IFA (indirect ﬂuorescent assay)
D. Immunochromatographic lateral-ﬂow assay
E. Latex agglutination
3. Which of the following is an appropriate treatment regimen for invasive amebi-
asis?
A. Ceftriaxone and metronidazole
B. Metronidazole or tinidazole
C. Paromomycin or diloxanide furoate
D. Metronidazole or tinidazole and paromomycin or diloxanide furoate
E. Co-trimoxazole
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